- Sections
- C - Chimiemétallurgie
- C40B - Chimie combinatoirebibliothèques, p. ex. chimiothèques
- C40B 30/02 - Criblage par ordinateur (in silico)
Détention brevets de la classe C40B 30/02
Brevets de cette classe: 222
Historique des publications depuis 10 ans
63
|
41
|
25
|
9
|
4
|
3
|
1
|
0
|
0
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
Caris MPI, Inc. | 102 |
7 |
The Regents of the University of California | 19868 |
6 |
Zymeworks Inc. | 256 |
5 |
Massachusetts Institute of Technology | 10036 |
4 |
Psomagen, Inc. | 92 |
4 |
Fujitsu Limited | 18343 |
3 |
Council of Scientific & Industrial Research | 1425 |
3 |
Immatics Biotechnologies GmbH | 1156 |
3 |
University Health Network | 1038 |
3 |
Novartis AG | 10867 |
2 |
The Board of Trustees of the Leland Stanford Junior University | 6402 |
2 |
National Taiwan University | 1218 |
2 |
Ancestry.com DNA, LLC | 133 |
2 |
Biolauncher Ltd. | 3 |
2 |
City of Hope | 986 |
2 |
Dacadoo AG | 51 |
2 |
GeneNews Corporation | 2 |
2 |
GenePeeks, Inc. | 5 |
2 |
iNova Health System | 10 |
2 |
Institute of Biophysics, Chinese Academy of Sciences | 122 |
2 |
Autres propriétaires | 162 |